[1] LEBLANC J G, CHAIN F, MARTIN R, et al.Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria[J].Microbial Cell Factories, 2017, 16(1):79.
[2] KERRY R G, PATRA J K, GOUDA S, et al.Benefaction of probiotics for human health:A review[J].Journal of Food and Drug Analysis, 2018, 26(3):927-939.
[3] MARKOWIAK KOPEC' P, S'LI ŻEWSKA K.The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome[J].Nutrients, 2020, 12(4):1 107.
[4] VISEKRUNA A, LUU M.The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis[J].Frontiers in Cell and Developmental Biology, 2021, 9:703218.
[5] MORRISON D J, PRESTON T.Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism[J].Gut Microbes, 2016, 7(3):189-200.
[6] SUN M M, WU W, LIU Z J, et al.Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases[J].Journal of Gastroenterol, 2017, 52(1):1-8.
[7] 王璐璇, 刘玥宏, 朱继开, 等.短链脂肪酸在疾病治疗中的研究进展[J].世界华人消化杂志, 2017, 25(13):1 179-1 186.
WANG L X, LIU Y H, ZHU J K, et al.Role of short-chain fatty acids in disease treatment[J].World Chinese Journal of Digestology, 2017, 25(13):1 179-1 186.
[8] TAN J, MCKENZIE C, POTAMITIS M, et al.The role of short-chain fatty acids in health and disease[J].Advances in Immunology, 2014, 121:91-119.
[9] VAN DER BEEK C M, LENAERTS K, VAN AVESAAT M, et al.670 Expression of the short-chain fatty acid receptors GPR41 and GPR43 throughout the human ileum and colon[J].Gastroenterology, 2015, 148(4):128-129.
[10] PENG Q, ZENG X F, ZHU J L, et al.Effects of dietary Lactobacillus plantarum B1 on growth performance, intestinal microbiota, and short chain fatty acid profiles in broiler chickens[J].Poultry Science, 2016, 95(4):893-900.
[11] OYARZABAL O A, CONNER D E.In vitro fructooligosaccharide utilization and inhibition of Salmonella spp.by selected bacteria[J].Poultry Science, 1995, 74(9):1 418-1 425.
[12] CHEN Z F,AL L Y,WANG J L, et al.Probiotics clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis[J].Futhre Microbiology, 2015, 10(9):1 433-1 445.
[13] RAGSDALE S W, PIERCE E.Acetogenesis and the wood-ljungdahl pathway of CO2 fixation[J].Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2008, 1 784(12):1 873-1 898.
[14] REY F E, FAITH J J, BAIN J, et al.Dissecting the in vivo metabolic potential of two human gut acetogens[J].Journal of Biological Chemistry, 2010, 285(29):22 082-22 090.
[15] REICHARDT N, DUNCAN S H, YOUNG P, et al.Phylogenetic distribution of three pathways for propionate production within the human gut microbiota[J].The ISME Journal, 2014, 8:1 323-1 335.
[16] HETZEL M, BROCK M, SELMER T, et al.Acryloyl-CoA reductase from Clostridium propionicum.An enzyme complex of propionyl-CoA dehydrogenase and electron-transferring flavoprotein[J].European Journal of Biochemistry, 2003, 270(5):902-910.
[17] SAXENA R K, ANAND P, SARAN S, et al.Microbial production and applications of 1,2-propanediol[J].Indian Journal of Microbiology, 2010, 50:2-11.
[18] DUNCAN S H, BARCENILLA A, STEWART C S, et al.Acetate utilization and butyryl coenzyme A (CoA):Acetate-CoA transferase in butyrate-producing bacteria from the human large intestine[J].Applied and Environmental Microbiology, 2002, 68(10):5 186-5 190.
[19] LOUIS P, DUNCAN S H, MCCRAE S I, et al.Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon[J].Journal of Bacteriology, 2004, 186(7):2 099-2 106.
[20] DUNCAN S H, LOUIS P, FLINT H J.Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product[J].Applied and Environmental Microbiology, 2004, 70(10):5 810-5 817.
[21] BOTTA C, ACQUADRO A, GREPPI A, et al.Genomic assessment in Lactobacillus plantarum links the butyrogenic pathway with glutamine metabolism[J].Scientific Reports, 2017, 7(1):15975.
[22] LOUIS P, HOLD G L, FLINT H J.The gut microbiota, bacterial metabolites and colorectal cancer[J].Nature Reviews Microbiology, 2014, 12(10):661-672.
[23] OHARA T, YOSHINO K, KITAJIMA M.Possibility of preventing colorectal carcinogenesis with probiotics[J].Hepato-gastroenterology, 2010, 57(104):1 411-1 415.
[24] FUKUDA S, TOH H, HASE K, et al.Bifidobacteria can protect from enteropathogenic infection through production of acetate[J].Nature, 2011, 469(7331):543-547.
[25] MASLOWSKI K M, VIEIRA A T, NG A, et al.Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J].Nature, 2009, 461(7268):1 282-1 286.
[26] HE T, ZHU Y H, YU J, et al.Lactobacillus johnsonii L531 reduces pathogen load and helps maintain short-chain fatty acid levels in the intestines of pigs challenged with Salmonella enterica Infantis[J].Veterinary Microbiology, 2019, 230:187-194.
[27] KLING D N, TEIXEIRA L D, DEBOSE-SCARLETT E M, et al.A Network of Physiological Interactions Modulating GI Homeostasis:Probiotics, Inflammasome, mTOR[M].2018, 70253(Chapter 2).
[28] DUCATELLE R, EECKHAUT V, HAESEBROUCK F, et al.A review on prebiotics and probiotics for the control of dysbiosis:Present status and future perspectives[J].Animal, 2015, 9(1):43-48.
[29] EJTAHED H S, MOHTADI-NIA J, HOMAYOUNI-RAD A, et al.Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus[J].Journal of Dairy Science, 2011, 94(7):3 288-3 294.
[30] WANG Y M, DILIDAXI D, WU Y C, et al.Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice[J].Biomedicine and Pharmacotherapy, 2020, 125:109914.
[31] TONUCCI L B, OLBRICH DOS SANTOS K M, LICURSI DE OLIVEIRA L, et al.Clinical application of probiotics in type 2 diabetes mellitus:A randomized, double-blind, placebo-controlled study[J].Clinical Nutrition, 2017, 36(1):85-92.
[32] TAMANG J P, SHIN D H, JUNG S J, et al.Functional properties of microorganisms in fermented foods[J].Frontiers in Microbiology, 2016, 7:578.
[33] ETTINGER G, MACDONALD K, REID G, et al.The influence of the human microbiome and probiotics on cardiovascular health[J].Gut Microbes, 2014, 5(6):719-728.
[34] FONTANÉ L, BENAIGES D, GODAY A, et al.Influence of the microbiota and probiotics in obesity[J].Clínica e Investigación En Arteriosclerosis, 2018, 30(6):271-279.
[35] MCINTOSH H.Directive art therapy and food addiction:Motivational tnterviewing and adjunctive art therapy in obesity management programs[J].Canadian Journal of Diabetes, 2013, 37:S269.
[36] HUANG Y C, WU B H, CHU Y L, et al.Effects of tempeh fermentation with Lactobacillus plantarum and Rhizopus Oligosporus on streptozotocin-induced type Ⅱ diabetes mellitus in rats[J].Nutrients,2018, 10(9): 1 143.
[37] JOSEPH N, VASODAVAN K, SAIPUDIN N A, et al.Gut microbiota and short-chain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration[J].Journal of Functional Foods, 2019, 57:103-111.
[38] NAGATA S, CHIBA Y, WANG C, et al.The effects of the Lactobacillus casei strain on obesity in children:A pilot study[J].Beneficial Microbes, 2017, 8(4), 535-543.
[39] YUSUF F, ABUBAKAR A.ADEWIAH S.Altered profile of gut microbiome and the level short chain fatty acids in colorectal cancer patients:257[J].American Journal of Gastroenterology, 2017, 112:S141.
[40] EDWARDS C A, HAVLIK J, CONG W, et al.Polyphenols and health:Interactions between fibre, plant polyphenols and the gut microbiota[J].Nutrition Bulletin, 2017, 42(4):356-360.
[41] CAVALCANTE R G S, DE ALBUQUERQUE T M R, DE LUNA FREIRE M O, et al.The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats[J].Nutrition, Metabolism and Cardiovascular Diseases, 2019, 29(12):1 408-1 417.
